About Bilhi Genetics
Bilhi Genetics is a company based in Marseille (France) founded in 2011 by Bruno Dessein and Pierre Dessein.. Bilhi Genetics has raised $1.35 million across 1 funding round. Bilhi Genetics operates in a competitive market with competitors including DNAnexus, Helix, Cytel, Benchling and BioAge Labs, among others.
- Headquarter Marseille, France
- Founders Bruno Dessein, Pierre Dessein
-
Sectors
HealthcareTechnology
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$1.35 M (USD)
in 1 rounds
-
Latest Funding Round
$1.35 M (USD), Seed
Feb 11, 2016
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Bilhi Genetics
Bilhi Genetics has successfully raised a total of $1.35M through 1 strategic funding round. The most recent funding activity was a Seed round of $1.35 million completed in February 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Seed — $1.4M
-
First Round
First Round
(11 Feb 2016)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2016 | Amount | Seed - Bilhi Genetics | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Bilhi Genetics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Bilhi Genetics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Bilhi Genetics Comparisons
Competitors of Bilhi Genetics
Bilhi Genetics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as DNAnexus, Helix, Cytel, Benchling and BioAge Labs, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Cloud-based genome informatics and data management are provided.
|
|
| domain | founded_year | HQ Location |
Genomic database for clinical research is provided.
|
|
| domain | founded_year | HQ Location |
Data analysis and statistical solutions are provided for life sciences.
|
|
| domain | founded_year | HQ Location |
Cloud-based bioinformatics platform is offered for biotech research.
|
|
| domain | founded_year | HQ Location |
Bioinformatics platform is provided for biomarkers and drug discovery.
|
|
| domain | founded_year | HQ Location |
Neurodegenerative disease drugs are developed using computational genomics.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Bilhi Genetics
When was Bilhi Genetics founded?
Bilhi Genetics was founded in 2011 and raised its 1st funding round 5 years after it was founded.
Where is Bilhi Genetics located?
Bilhi Genetics is headquartered in Marseille, France. It is registered at Marseille, Provence-alpes-cote D'azur, France.
Who is the current CEO of Bilhi Genetics?
Pierre Dessein is the current CEO of Bilhi Genetics. They have also founded this company.
Is Bilhi Genetics a funded company?
Bilhi Genetics is a funded company, having raised a total of $1.35M across 1 funding round to date. The company's 1st funding round was a Seed of $1.35M, raised on Feb 11, 2016.
What does Bilhi Genetics do?
Bilhi Genetics was founded in 2011 in Marseille, France, focusing on biotechnology and genetic research. Algorithms for predicting diseases through genetic markers are developed in partnership with UMR 906. A panel exceeding 40 markers for acute liver fibrosis prediction has been identified. Genetic polymorphisms associated with keloid and hypertrophic scars have been pinpointed, with a predictive algorithm under development for pre-surgical assessment.